Patrick Caplazi
0000-0002-3411-1257
Genentech Research
3 papers found
Refreshing results…
LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung
Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidone
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis
Missing publications? Search for publications with a matching author name.